JournalQ1· SCImago 2025
Clinical Infectious Diseases
ISSN 1058-4838
- Q1Quartile
- 2.00SJR
- 414h-index
- 21papers summarised
About this journal
Clinical Infectious Diseases is a Q1 journal by SCImago Journal Rank (2025 data), with an SJR of 2.00 and an h-index of 414. Pofolia holds AI summaries of 21 paper(s) from this journal; the most cited is “Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan…” (5039 citations).
The quartile (Q1–Q4) is the journal's percentile position within its subject area by SCImago Journal Rank; Q1 is the top 25%. What is a Q1 journal? · What is the h-index?
Papers we summarise from this journal
- Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China2020 · 5039 citations
- Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America2015 · 4074 citations
- Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society2016 · 3949 citations
- Diagnosis and Management of Prosthetic Joint Infection: Clinical Practice Guidelines by the Infectious Diseases Society of Americaa2012 · 2246 citations
- DALI: Defining Antibiotic Levels in Intensive Care Unit Patients: Are Current -Lactam Antibiotic Doses Sufficient for Critically Ill Patients?2014 · 1091 citations
- Cross-sectional Comparison of the Prevalence of Age-Associated Comorbidities and Their Risk Factors Between HIV-Infected and Uninfected Individuals: The AGEhIV Cohort Study2014 · 775 citations
- Weight Gain Following Initiation of Antiretroviral Therapy: Risk Factors in Randomized Comparative Clinical Trials2019 · 757 citations
- IDSA Clinical Practice Guideline for Acute Bacterial Rhinosinusitis in Children and Adults2012 · 593 citations
- Executive Summary: IDSA Clinical Practice Guideline for Acute Bacterial Rhinosinusitis in Children and Adults2012 · 501 citations
- <i>Nocardia</i>Infection in Solid Organ Transplant Recipients: A Multicenter European Case-control Study2016 · 256 citations
- Outcome and Treatment of Nocardiosis After Solid Organ Transplantation: New Insights From a European Study2017 · 121 citations
- Nocardia-Induced Granulocyte Macrophage Colony-Stimulating Factor Is Neutralized by Autoantibodies in Disseminated/Extrapulmonary Nocardiosis2014 · 100 citations
- Generating Actionable Data From Antimicrobial Resistance Surveillance: Insights From the Fleming Fund's International Experience2026 · 4 citations
- Surveillance Data Use Through the Fleming Fund: Informing Action on Antimicrobial Resistance in Low- and Middle-Income Countries2026 · 4 citations
- Fleming Fund Implementation in Kenya: What Have We Learned About Strengthening One Health Antimicrobial Resistance Surveillance for Decision-making?2026 · 4 citations
- Antenatal Screening for Sexually Transmitted Infections to Reduce Preterm Birth or Low Birthweight (Philani Ndiphile Study): A Randomized 3-Group Trial2026 · 3 citations
- Antimicrobial Resistance and One Health: Lessons on One Health Governance and Implementation from the Fleming Fund2026 · 3 citations
- Changing National and Regional Trends in Drug Use-Associated Infective Endocarditis From 2016 to 20222026 · 1 citations
- Enabling Ciprofloxacin Resistance-Guided Therapy for Neisseria gonorrhoeae : Aligning Diagnostics, Regulation, Guidelines, and Reimbursement2026 · 1 citations
- Reflections for the Future of AMR Surveillance and AMR Action2026 · 1 citations
- Association Between Neighbourhood-level Antibiotic Utilization and the Rate of Community-Associated C. difficile (CA-CDI) Infection: An Ecological Study2026 · 0 citations
Journals in the same field
| Journal | Quartile | SJR | Summaries |
|---|---|---|---|
| Frontiers in Immunology | Q1 | 1.00 | 1 |
| Open Forum Infectious Diseases | Q1 | 1.00 | 1 |
| Life | Q1 | 1 | |
| Biology | Q1 | 1 |
Follow these journals on Pofolia
Pick your fields and new papers from their journals land in your feed every day with AI summaries. Free.
Start free